Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision history now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This updates the revision record without altering the study details.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision/version label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page version.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page’s footer now shows a newer site “Revision” version (v3.5.3 instead of v3.5.2), indicating a ClinicalTrials.gov site software update.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a site maintenance/version update with no visible changes to the study details.SummaryDifference0.0%

- Check95 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.